MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

The latest financial statement is for the year ending 2025-12-31.

Cash Flow Overview

Free Cash flow
-$196,042K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from maturities of shor...
    • Proceeds from long-term debt, ne...
    • Issuance of class a ordinary sha...
    • Others
Negative Cash Flow Breakdown
    • Purchase of short-term marketabl...
    • Net loss
    • Other receivables
    • Others

Cash Flow
2025-12-31
Net loss
-230,321
Depreciation and amortization
2,616
Share-based compensation expense
12,898
Net periodic pension benefit (gain) loss for the qualified pension plan
-58
Other non-cash items
1,020
Other receivables
2,025
Operating lease right-of-use assets
0
Prepaid expenses
-561
Other non-current assets
587
Trade and other payables
20,560
Operating lease liabilities
-1,222
Accrued expenses and other current liabilities
2,591
Net cash flow used in operating activities
-196,007
Purchase of short-term marketable debt securities
265,374
Proceeds from maturities of short-term marketable debt securities
468,401
Purchase of property and equipment
35
Net cash flow provided by (used in) investing activities
202,992
Proceeds from long-term debt, net of issuance costs
73,022
Issuance of class a ordinary shares, net of transaction costs
72,395
Stamp duty on capital injection from moonlake to moonlake ag
0
Proceeds from stock options exercised-Equity Incentive Plan
480
Proceeds from stock options exercised-Employee Stock Option Plan ESOP
100
Net cash flow provided by financing activities
145,997
Effect of movements in exchange rates on cash held
1,109
Net change in cash and cash equivalents
154,091
Cash and cash equivalents, beginning of period
180,426
Cash and cash equivalents, end of period
334,517
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from maturitiesof short-term...$468,401K Proceeds from long-termdebt, net of issuance...$73,022K Issuance of class aordinary shares, net of...$72,395K Proceeds from stockoptions...$480K Proceeds from stockoptions...$100K Net cash flowprovided by (used in)...$202,992K Net cash flowprovided by financing...$145,997K Effect of movements inexchange rates on cash...$1,109K Canceled cashflow$265,409K Net change in cashand cash...$154,091K Canceled cashflow$196,007K Purchase of short-termmarketable debt securities$265,374K Purchase of property andequipment$35K Trade and otherpayables$20,560K Share-based compensationexpense$12,898K Depreciation andamortization$2,616K Accrued expenses andother current...$2,591K Prepaid expenses-$561K Net cash flow used inoperating activities-$196,007K Canceled cashflow$39,226K Net loss-$230,321K Other receivables$2,025K Operating leaseliabilities-$1,222K Other non-cash items$1,020K Other non-currentassets$587K Net periodicpension benefit (gain)...-$58K

MoonLake Immunotherapeutics (MLTX)

MoonLake Immunotherapeutics (MLTX)